|
Author: M. Humbert, G. Simonneau and L.J. Rubin Date Published: December-2011 Source: European Respiratory Review
The past decade has witnessed unprecedented change in the field of pulmonary hypertension (PH). PH has previously been called an orphan disease; that is, a condition that affects few individuals and is overlooked by the medical profession and pharmaceutical companies.
|